Congenital adrenal hyperplasia: Diagnostic advances
Congenital adrenal hyperplasia is a group of autosomal recessive disorders resulting from the deficiency of one of the five enzymes required for the synthesis of cortisol in the adrenal cortex. The most frequent is steroid 21-hydroxylase deficiency, accounting for more than 90% of cases. Much has been learned about the genetics of the various clinical forms of 21-hydroxylase deficiency, and correlations between the genotype and the phenotype have been studied extensively. Gene-specific diagnosis is now feasible and neonatal screening and prenatal treatment have been widely implemented. This discussion will be limited to the most common form of congenital adrenal hyperplasia, with focus on the diagnostic advances in this disease.
KeywordsCongenital Adrenal Hyperplasia Newborn Screening Neonatal Screening Androgen Excess Ligase Detection Reaction
Unable to display preview. Download preview PDF.
- Day DJ, Speiser PW, White PC, Barany F (1995) Detection of steroid 21-hydroxylase alleles using gene-specific PCR and a multiplexed ligation detection reaction. Genomics 29: 152-162.Google Scholar
- Janzen N, Peter M, Sander S, et al (2007) Newborn screening for congenital adrenal hyperplasia: additional steroid profile using liquid chromatography-tandem mass spectrometry. J Clin Endocrinol Metab 92: 2581–2589.Google Scholar
- Krone N, Braun A, Weinert S, et al (2002) Multiplex minisequencing of the 21-hydroxylase gene as a rapid strategy to confirm congenital adrenal hyperplasia. Clinical Chemistry 48: 818–825.Google Scholar
- Torresani T, Gruters A, Scherz R, Burckhardt JJ, Harras A, Zachmann M (1994) Improving the efficacy of newborn screening for congenital adrenal hyperplasia by adjusting the cut-off level of 17α-hydroxyprogesterone to gestational age. Screening 3: 77–84.Google Scholar
- van der Kamp H, Oudshoorn C, Elvers B, et al (2005) Cutoff levels of 17α-hydroxyprogesterone in neonatal screening for congenital adrenal hyperplasia should be based on gestational age rather than on birth weight. J Clin Endocrinol Metab 90: 3904–3907.Google Scholar